83 related articles for article (PubMed ID: 106479)
1. Antibacterial activity of nitroxoline and sulphamethizole alone and in combination in urinary tract infections.
Jacobs MR; Robinson RG; Koornhof HJ
S Afr Med J; 1978 Dec; 54(23):959-62. PubMed ID: 106479
[TBL] [Abstract][Full Text] [Related]
2. Urinary concentrations and urine ex-vivo effect of mecillinam and sulphamethizole.
Kerrn MB; Frimodt-Møller N; Espersen F
Clin Microbiol Infect; 2004 Jan; 10(1):54-61. PubMed ID: 14706087
[TBL] [Abstract][Full Text] [Related]
3. [Inhibition of bacterial adhesion of uropathogenic Escherichia coli strains by the urine of patients treated with nitroxoline].
Karam D; Amgar A; Bourlioux P
Pathol Biol (Paris); 1988 May; 36(5):452-5. PubMed ID: 3043342
[TBL] [Abstract][Full Text] [Related]
4. Comparison of trimethoprim alone with co-trimoxazole and sulphamethizole for treatment of urinary tract infections.
Keenan TD; Eliott JC; Bishop V; Peddie BA; Bailey RR
N Z Med J; 1983 May; 96(731):341-2. PubMed ID: 6341904
[TBL] [Abstract][Full Text] [Related]
5. [Effect of the combination of 5-methylquinolin-8-ol, 7-bromo-5-methylquinolin-8-ol and 5-methylquinolin-8-ol-dodecylsulfate on the intestinal flora of healthy subjects].
Hoffmann K
Arzneimittelforschung; 1975 Jun; 25(6):956-8. PubMed ID: 809045
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of inhibitory activity of colistin on Pseudomonas aeruginosa by sulphamethoxazole and sulphamethizole.
Simmons NA
Br Med J; 1969 Sep; 3(5672):693-6. PubMed ID: 4980194
[TBL] [Abstract][Full Text] [Related]
7. Sulphamethizole in urinary tract infections.
Peddie BA; Little PJ
J Antimicrob Chemother; 1979 Mar; 5(2):195-200. PubMed ID: 34595
[No Abstract] [Full Text] [Related]
8. Comparative trial of sulphadiazine-trimethoprim (co-trimazine), co-trimoxazole and sulphamethizole in the treatment of uncomplicated urinary tract infections.
Bailey RR; Pearson S
N Z Med J; 1980 Jan; 91(652):43-4. PubMed ID: 6990320
[TBL] [Abstract][Full Text] [Related]
9. [Urinary tract infections in general practice. III. Treatment with sulphamethizole, trimethoprim or co-trimazin (sulphadiazine-trimethoprim].
Mabeck CE; Vejlsgaard R
Ugeskr Laeger; 1980 Jun; 142(26):1664-8. PubMed ID: 6996257
[No Abstract] [Full Text] [Related]
10. Urinary concentrations and bactericidal activities of newer fluoroquinolones in healthy volunteers.
Stein GE; Schooley S
Int J Antimicrob Agents; 2004 Aug; 24(2):168-72. PubMed ID: 15288316
[TBL] [Abstract][Full Text] [Related]
11. Clinical pharmacokinetics of nitroxoline.
Mrhar A; Kopitar Z; Kozjek F; Presl V; Karba R
Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):476-81. PubMed ID: 118941
[TBL] [Abstract][Full Text] [Related]
12. [Spasmolytic and anti-inflammatory activity of 8-hydroxyquinolines].
Zaks AS; Zil'ber AL; Kapitonenko TA
Farmakol Toksikol; 1984; 47(5):44-7. PubMed ID: 6238840
[TBL] [Abstract][Full Text] [Related]
13. Urinary tract pathogens-sensitivity to trimethoprim/sulphamethoxazole.
Laursen H; Nielsen ML
Scand J Infect Dis; 1970 Dec; 2(3):205-9. PubMed ID: 25607580
[TBL] [Abstract][Full Text] [Related]
14. [Sensitivity of E. coli to intestopan].
Sedova NN
Lab Delo; 1980; (8):493-4. PubMed ID: 6157907
[No Abstract] [Full Text] [Related]
15. [Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].
Hausnerová S; Tesarová Z; Uhlír O
Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):97-101. PubMed ID: 124227
[No Abstract] [Full Text] [Related]
16. [In vitro antifungal activity of nitroxoline. Preliminary clinical results].
Cancet B; Amgar A
Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):879-81. PubMed ID: 3309833
[TBL] [Abstract][Full Text] [Related]
17. Simple additives to increase the activity of chlorhexidine digluconate against urinary pathogens.
Harper WE
Paraplegia; 1983 Apr; 21(2):86-93. PubMed ID: 6408586
[TBL] [Abstract][Full Text] [Related]
18. [Comparative antibacterial activity of piperacillin against Pseudomonas aeruginosa, Escherichia coli and Streptococcus faecalis in cultures and human serum].
Just HM; Reiber T; Bassler M; Daschner FD
Immun Infekt; 1985 May; 13(3):119-23. PubMed ID: 3924819
[TBL] [Abstract][Full Text] [Related]
19. The use of trimethoprim-sulphamethoxazole in the treatment of complicated urinary tract infection.
Sillar S
Aust N Z J Surg; 1972 May; 41(4):368-71. PubMed ID: 4623553
[No Abstract] [Full Text] [Related]
20. [Bacterial pathogens, resistance patterns and treatment options in community acquired pediatric urinary tract infection].
Pape L; Gunzer F; Ziesing S; Pape A; Offner G; Ehrich JH
Klin Padiatr; 2004; 216(2):83-6. PubMed ID: 15106080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
